Novo Nordisk A/S (NYSE:NVO) Reported Basic Consolidated EPS Of $1.8013 For Period Ended 2014-12-31

0

The annual basic consolidated EPS for Novo Nordisk A/S (NYSE:NVO) for the period ended 2014-12-31 was $1.8013. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2014-12-31 was $1.8013.

EPS from continuing operations

Coming to basic EPS from continuing operations, Novo Nordisk A/S (NYSE:NVO) reported $1.8013 for the annual period ended 2014-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2014-12-31 stood at $1.8013.

EPS contribution from parent

For the annual period ended 2014-12-31, Novo Nordisk A/S (NYSE:NVO) received basic EPS of $1.8013 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2014-12-31 was $1.8013.

Basic net EPS

For the annual period ended 2014-12-31, Novo Nordisk A/S (NYSE:NVO) reported basic net EPS of $1.8008. On quarterly basis, the company’s basic net EPS for the three-month period ended 2014-12-31 stood at $1.8008.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2014-12-31 stood at $1.7951. For the quarter ended 2014-12-31, consolidated diluted EPS was $1.7951.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $1.7951 for the period ended 2014-12-31. Diluted EPS from continuing operations for the quarter ended 2014-12-31 was $1.7951.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2014-12-31 was $1.7955. For the quarterly period ended 2014-12-31, net diluted EPS was $1.7955.

Diluted EPS from parent

From the parent company, Novo Nordisk A/S (NYSE:NVO) received diluted EPS of $1.7951 for the annual period ended 2014-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2014-12-31 was $1.7951.

Novo Nordisk A/S (NYSE:NVO) posted net basic EPS reading of $2.02 for the annual period ended 2014-12-31. For the quarter, basic net EPS of $2.02 was for the quarter ended 2014-12-31.

Net diluted EPS for Novo Nordisk A/S (NYSE:NVO) for the annual period ended 2014-12-31 was $2.01. The company also reported net diluted EPS reading of $2.01 for the quarter ended 2014-12-31.

The annual average basic shares outstanding for the period ended 2014-12-31 is 2570.796 while for the quarter ended 2014-12-31 is 2570.796.

The diluted shares outstanding for the fiscal year ended is 2014-12-31 is 2570.796 while for the quarter ended 2014-12-31 is 2570.796.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 18 times, 1 visits today)